Related Experiment Video
Updated: Jul 12, 2026
Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
Published on: June 7, 2020
A novel molecular assay to discriminate transcriptional effects caused by xenoestrogens
Mohammad Kazem Koohi1, Norbert Walther, Richard Ivell
1Institute for Hormone and Fertility Research, University of Hamburg, 20246 Hamburg, Germany.
Abstract:
A phenotypic definition of the term estrogen has become increasingly problematic due to the multiple modes of estrogen action which can now be defined by differing nuclear and membrane receptors for the classic ligand, 17beta-estradiol, and by the multiple signalling pathways that are consequently addressed. This has led to the term xenoestrogen being largely determined by whatever assay system is used for its definition. Here we describe a novel and simple matrix for a transfection system using MBA-MD231 and MCF-7 breast cancer cells as hosts. This matrix is able to vary the type of nuclear estrogen receptor used, and by varying the promoter-reporter construct between one using a classic estrogen response element (ERE) enhancer, and one using an enhancer element derived from the bovine oxytocin gene promoter binding an orphan nuclear receptor, direct classical effects can be neatly discriminated from non-classical and non-genomic actions of test substances. This assay matrix has been used to examine a selection of phytoestrogens and xenobiotics, thereby providing new information on the mechanism of action of some of these substances in breast cancer cells.
Insights
Defining estrogen action is complex due to multiple receptors and pathways. This study introduces a new assay to distinguish direct estrogen effects from non-classical actions of compounds like phytoestrogens and xenobiotics.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- The definition of estrogen action is complicated by diverse nuclear and membrane receptor interactions and signaling pathways.
- The term xenoestrogen is often defined by the specific assay system used, leading to ambiguity.
- Understanding the precise mechanisms of estrogenic compounds is crucial for assessing their impact, especially in breast cancer.
Purpose of the Study:
- To develop a novel transfection assay matrix for discriminating between classical and non-classical estrogenic actions.
- To differentiate genomic and non-genomic effects of various substances on breast cancer cells.
- To investigate the mechanisms of action for selected phytoestrogens and xenobiotics using the developed assay.
Main Methods:
- Utilized a transfection system with MBA-MD231 and MCF-7 breast cancer cells.
- Varied the type of nuclear estrogen receptor and promoter-reporter constructs.
- Employed an estrogen response element (ERE) enhancer and a bovine oxytocin gene promoter enhancer to distinguish signaling pathways.
Main Results:
- Successfully discriminated direct classical estrogen effects from non-classical and non-genomic actions.
- Applied the assay to analyze phytoestrogens and xenobiotics, yielding new mechanistic insights.
- Demonstrated the utility of the assay matrix in characterizing the diverse actions of endocrine-disrupting compounds.
Conclusions:
- The developed assay provides a robust method for dissecting complex estrogen signaling.
- This approach clarifies the mechanisms of action for various phytoestrogens and xenobiotics in breast cancer cells.
- Offers a valuable tool for future research on endocrine disruptors and their effects.
